Certara, Inc. (CERT) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-22

Key Insights

Certara is divesting its global medical writing and regulatory services business to Veristat for $100 million upfront cash plus up to $35 million in contingent earn-out payments, representing a strategic portfolio optimization to focus on core operations.
The transaction structure includes $15 million held in escrow pending satisfaction of closing conditions, providing some downside protection while the earn-out component ties future value realization to post-closing business performance over a specified period.
The deal is subject to customary closing conditions including material adverse effect clauses and completion of internal reorganization steps, with transition services to be provided post-closing, indicating an orderly separation process.

Want the newest filings?

This analysis covers the filing from 2026-04-22. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-03-31

Cynthia Collins, a director and member of the Audit Committee, has announced her resignation from the Certara, Inc. Board of Directors effective May 14, 2026.
The resignation does not appear to be due to any disagreement with the company's operations, policies or practices, according to the filing.
The departure of a director, especially one serving on a key committee like Audit, could signal changes in Certara's leadership or governance structure.

Filed: 2026-02-26

Certara, Inc. announced its financial results for the fourth quarter of 2025, indicating the company's continued growth and operational performance.
The press release highlights the company's revenue and profitability metrics, which appear to be in line with or exceeding investor expectations.
Certara's management team and operations seem stable, with no significant leadership changes or other material events reported in the 8-K filing.

Other reports for Certara, Inc.

Insider Trading Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.